System-generated · Sector Rotation (rank-driven) · stock · inception 2026-07-04
Started with ₹10,00,000 · max 10% per position (10 slots).
Sector Rotation — catching sectors as they turn, before they lead.
This rulebook was chosen by the system’s walk-forward search, not hand-written — the exact filters above are what won on out-of-sample data. See the Learning log below for how it got here and what it rejected.
Execution costs of ₹9,57,198 are already inside this curve. Realized tax (FIFO, STCG/LTCG netted per FY): ₹17,65,880 → post-tax total return -37.0% vs +139.6% pre-tax.
Two curves: With 10% stop (the live rule — exit any position that closes 10% below its entry) vs No stop. On this book the stop is a net win — it cuts drawdown and lifts return by cutting real losers early.
Survivor-only backtest. The universe is today’s Atlas-scored names applied backwards, so stocks that delisted or collapsed never appear. Real drawdowns would be worse — read these returns as an optimistic upper bound, not a promise.
Thick bar = this portfolio · thin bar = NIFTY 500 sector weight.
| Instrument | Sector | Qty | Avg cost | Last | Value | Weight | P&L | Comp | Tech | Flow | Val | RS 3M | EMA 50/200 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GRANULES Granules India Limited | Healthcare | 119 | 833.80 | 882.05 | ₹1,04,964 | 10.6% | +5.8% | 95 | 100 | 50 | 29 | +36.3% | ✓/✓ |
| JBCHEPHARM JB Chemicals & Pharmaceuticals Limited | Pharma | 42 | 2364.60 | 2444.50 | ₹1,02,669 | 10.3% | +3.4% | 95 | 100 | 50 | 3 | +18.6% | ✓/✓ |
| LUPIN Lupin Limited | Pharma | 40 | 2459.00 | 2503.30 | ₹1,00,132 | 10.1% | +1.8% | 95 | 100 | 50 | 35 | +4.0% | ✓/✓ |
| IPCALAB IPCA Laboratories Limited | Pharma | 56 | 1778.90 | 1770.40 | ₹99,142 | 10.0% | -0.5% | 96 | 100 | 58 | 17 | +18.3% | ✓/✓ |
| NUVAMA Nuvama Wealth Management Limited | Capital Markets | 51 | 2003.60 | 1934.60 | ₹98,665 | 9.9% | -3.4% | 95 | 100 | 50 | 17 | +44.8% | ✓/✓ |
| ZYDUSLIFE Zydus Lifesciences Limited | Pharma | 85 | 1148.00 | 1159.00 | ₹98,515 | 9.9% | +1.0% | 96 | 100 | 60 | 34 | +23.3% | ✓/✓ |
| ANANDRATHI Anand Rathi Wealth Limited | Capital Markets | 47 | 2087.63 | 2095.60 | ₹98,493 | 9.9% | +0.4% | 94 | 100 | 40 | 0 | +13.8% | ✓/✓ |
| TORNTPHARM Torrent Pharmaceuticals Limited | Pharma | 20 | 4866.40 | 4898.20 | ₹97,964 | 9.9% | +0.7% | 95 | 100 | 50 | 0 | +14.6% | ✓/✓ |
| DIVISLAB Divi's Laboratories Limited | Pharma | 14 | 6755.00 | 6813.00 | ₹95,382 | 9.6% | +0.9% | 91 | 95 | 50 | 0 | +8.1% | ✓/✓ |
No policy cycles yet — the weekly walk-forward run writes here.
| Date | Instrument | Side | Qty | Price | Value | Cost | Realized P&L | Days | Bucket | Tax | Reason |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-10 | ANANDRATHI | buy | 47 | 2095.60 | ₹98,493 | ₹116.22 | — | — | — | — | signal |
| 2026-07-10 | NUVAMA | buy | 51 | 1934.60 | ₹98,665 | ₹116.42 | — | — | — | — | signal |
| 2026-07-10 | FORTIS | sell | 102 | 951.45 | ₹97,048 | ₹99.96 | ₹-2,579 | 4 | stcg | ₹0.00 | signal |
| 2026-07-10 | GLAND | sell | 39 | 2469.50 | ₹96,311 | ₹99.20 | ₹-1,240 | 1 | stcg | ₹0.00 | signal |
| 2026-07-09 | LUPIN | buy | 40 | 2459.00 | ₹98,360 | ₹116.06 | — | — | — | — | signal |
| 2026-07-09 | GLAND | buy | 39 | 2495.80 | ₹97,336 | ₹114.86 | — | — | — | — | signal |